Crystallographic Studies of Prion Protein (PrP) Segments Suggest How Structural Changes Encoded by Polymorphism at Residue 129 Modulate Susceptibility to Human Prion Disease

被引:52
作者
Apostol, Marcin I. [1 ]
Sawaya, Michael R. [1 ]
Cascio, Duilio [1 ]
Eisenberg, David [1 ]
机构
[1] Univ Calif Los Angeles, UCLA DOE Inst, Dept Chem & Biochem, Howard Hughes Med Inst, Los Angeles, CA 90095 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
X-RAY-DIFFRACTION; CROSS-BETA SPINE; CONFORMATIONAL CONVERSION; NMR STRUCTURE; GENOTYPE; VARIANT; MODEL; REPLICATION; DOMAIN; CJD;
D O I
10.1074/jbc.C110.158303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A single nucleotide polymorphism (SNP) in codon 129 of the human prion gene, leading to a change from methionine to valine at residue 129 of prion protein (PrP), has been shown to be a determinant in the susceptibility to prion disease. However, the molecular basis of this effect remains unexplained. In the current study, we determined crystal structures of prion segments having either Met or Val at residue 129. These 6-residue segments of PrP centered on residue 129 are "steric zippers," pairs of interacting beta-sheets. Both structures of these " homozygous steric zippers" reveal direct intermolecular interactions between Met or Val in one sheet and the identical residue in the mating sheet. These two structures, plus a structure-based model of the heterozygous Met-Val steric zipper, suggest an explanation for the previously observed effects of this locus on prion disease susceptibility and progression.
引用
收藏
页码:29671 / 29675
页数:5
相关论文
共 49 条
[1]   Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease [J].
Alperovitch, A ;
Zerr, I ;
Pocchiari, M ;
Mitrova, E ;
Cuesta, JD ;
Hegyi, I ;
Collins, S ;
Kretzschmar, H ;
van Duijn, C ;
Will, RG .
LANCET, 1999, 353 (9165) :1673-1674
[2]   Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231 [J].
Apetri, AC ;
Vanik, DL ;
Surewicz, WK .
BIOCHEMISTRY, 2005, 44 (48) :15880-15888
[3]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[4]   The presence of valine at residue 129 in human prion protein accelerates amyloid formation [J].
Baskakov, I ;
Disterer, P ;
Breydo, L ;
Shaw, M ;
Gill, A ;
James, W ;
Tahiri-Alaoui, A .
FEBS LETTERS, 2005, 579 (12) :2589-2596
[5]   Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK [J].
Brandel, JP ;
Preece, M ;
Brown, P ;
Croes, E ;
Laplanche, JL ;
Agid, Y ;
Will, R ;
Alpérovitch, A .
LANCET, 2003, 362 (9378) :128-130
[6]   Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD [J].
Collinge, J ;
Sidle, KCL ;
Meads, J ;
Ironside, J ;
Hill, AF .
NATURE, 1996, 383 (6602) :685-690
[7]   A general model of prion strains and their pathogenicity [J].
Collinge, John ;
Clarke, Anthony R. .
SCIENCE, 2007, 318 (5852) :930-936
[8]   Kuru in the 21st century - an acquired human prion disease with very long incubation periods [J].
Collinge, John ;
Whitfield, Jerome ;
McKintosh, Edward ;
Beck, John ;
Mead, Simon ;
Thomas, Dafydd J. ;
Alpers, Michael P. .
LANCET, 2006, 367 (9528) :2068-2074
[9]  
DeLano W.L., 2002, The PyMOL molecular graphics system
[10]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132